![[E] NHS England Specialist Commissioning guidance Lung volume reduction by surgery or endobronchial valve for severe emphysema in adults.pdf](/uploads/r/null/6/5/0/65076b7c0849f0c0189a18b39d622f8c5f226e0f2174c0a89619ea0ce428ae39/9fa6c55e-43be-4475-81f1-545d6d18480f-_E__NHS_England_Specialist_Commissioning_guidance_Lung_volume_reduction_by_surgery_or_endobronchial_valve_for_severe_emphysema_in_adults_142.jpg)
590 résultats avec objets numériques
Afficher les résultats avec des objets numériques
![[A] The World Health Organization (2016). Combating Hepatitis B and C to Reach Elimination by 2030.pdf](/uploads/r/null/d/c/d/dcdc14440b46f5b8526bbffad5b736e1f9b53dd3f946af9d97ec155a836e1fc4/cef9cd25-4355-4e2a-8213-f50dc840a3c4-_A__The_World_Health_Organization__2016_._Combating_Hepatitis_B_and_C_to_Reach_Elimination_by_2030_142.jpg)
![[G] The World Health Organization China (2015) Policy Brief The case for investing in hepatitis B and C treatment in China.pdf](/uploads/r/null/e/a/2/ea2061a05d09cd2bfdf4ac684db4682d80008b4bc247f1dd853841a684a03fa8/e266c1a7-8456-445c-af98-47aeec597201-_G__The_World_Health_Organization_China__2015__Policy_Brief_The_case_for_investing_in_hepatitis_B_and_C_treatment_in_China_142.jpg)
![[A] Corticosteroids for COVID-19 (who.int).pdf](/uploads/r/null/8/a/5/8a57953e29db1656a69b65752e86a618a2da0110e4badfa761e53c023b006032/6b7edc8d-e307-4ce3-8400-6f481640718e-_A__Corticosteroids_for_COVID-19__who.int__142.jpg)
Pièce
Fait partie de UoA 1
![[D] NICE COVID-19 prescribing briefing for the use of corticosteroids. .pdf](/uploads/r/null/e/8/7/e8751c317432764b02848ac4f44029c3a771f967ac84387b50f047cfa8fb7beb/8c5c0994-9096-4843-bcd8-3344d6037e47-_D__NICE_COVID-19_prescribing_briefing_for_the_use_of_corticosteroids.__142.jpg)
Pièce
Fait partie de UoA 1
![[A] UK SAGE committee meeting minutes 29th October 2014.pdf](/uploads/r/null/3/e/a/3eab7791bdd0ceb4e1818e3589c6488430d400b745f5c71463849eacfd086c20/f3846e4a-d8fd-4139-870c-e1b3cc964542-_A__UK_SAGE_committee_meeting_minutes_29th_October_2014_142.jpg)
Pièce
Fait partie de UoA 1
![[C] South African HIV Society ART guidelines for adults .pdf](/uploads/r/null/f/9/d/f9d0c9ccba1cef71b267ddb0f69b8fa03aa58e98e7b8ceabe8a71f3a71667ebc/b3ba5934-e574-4c83-9a03-70182e830d35-_C__South_African_HIV_Society_ART_guidelines_for_adults__142.jpg)
Pièce
Fait partie de UoA 1
![[E] WHO Guidelines for the treatment of latent tuberculosis – 2018..pdf](/uploads/r/null/7/4/b/74b3751b0dd67a6c1ec3d4188f4aace19a1453fb09b2aecbcd467a5c8319a04b/a281fca4-bd95-40bf-aa48-8628d0853c54-_E__WHO_Guidelines_for_the_treatment_of_latent_tuberculosis_-_2018._142.jpg)
Pièce
Fait partie de UoA 1
![[G] Guidelines for the Treatment of Latent Tuberculosis Infection Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 Morbidity and Mortality Weekly Report February 14 2020.pdf](/uploads/r/null/4/6/e/46ed66d453821f0ddccadce5494a4e14439887fe2a0f1a6659e92729d89545c6/e42813dc-061f-4c04-89f6-a6dc91eafef5-_G__Guidelines_for_the_Treatment_of_Latent_Tuberculosis_Infection_Recommendations_from_the_National_Tuberculosis_Controllers_Association_and_CDC__2020_Morbidity_and_Mortality_Weekly_Report_February_14_2020_142.jpg)
![[A] Background brief on the proposed targets and estimated costs of implementation of the draft Global Technical Strategy for Malaria (2016-2030).pdf](/uploads/r/null/6/0/0/6001ec38077a120fcf6272e9729a49c761e106f12407645f5dd32fe38dcbaebf/6007b84c-0ed2-4640-a4fb-3b4eb2563fb6-_A__Background_brief_on_the_proposed_targets_and_estimated_costs_of_implementation_of_the_draft_Global_Technical_Strategy_for_Malaria__2016-2030__142.jpg)
![[B] Action and Investment to Defeat Malaria, 2016-2030 For a Malaria Free World.pdf](/uploads/r/null/f/f/1/ff13774857a5cc50e08b241e0147196738f4e8c508dec48ef313afaba9cf940a/171020f2-2f60-40a2-a77a-6cfe5910821e-_B__Action_and_Investment_to_Defeat_Malaria__2016-2030_For_a_Malaria_Free_World_142.jpg)
Pièce
Fait partie de UoA 2
![[D] Sixth Global Fund Investment Case.pdf](/uploads/r/null/9/8/c/98c5448b41333a237ef0ab953cf4d84972d6f2e7598b5a317dd849502fbddabf/e6f3f941-320c-42fe-be3c-32c6afc41488-_D__Sixth_Global_Fund_Investment_Case_142.jpg)
Pièce
Fait partie de UoA 2
![[E] Fifth Global Fund Cycle Modelling informing Global Fund strategy targets Report to the Board.pdf](/uploads/r/null/5/c/4/5c4cd9e19d7544a5eda2b278680063c001d49ec4b3870a25f51d5d4ffb559d53/e891430a-fb34-4d31-b427-4598d78af618-_E__Fifth_Global_Fund_Cycle_Modelling_informing_Global_Fund_strategy_targets_Report_to_the_Board_142.jpg)
![[H] National Malaria Elimination Strategic Plan 2017-2021, National Malaria Elimination Centre, Zambia.pdf](/uploads/r/null/e/a/7/ea7e0e65290408053c30a9b1fbd4783193f2aab0f3a0f554f1fd55d6b115bfc9/cabb656e-e218-4352-ba8e-99e4c85e9b16-_H__National_Malaria_Elimination_Strategic_Plan_2017-2021__National_Malaria_Elimination_Centre__Zambia_142.jpg)
![[A] Shape of training. Securing the future of excellent patient care. Final report of the independent review. Led by Professor David Greenaway. October 2013.pdf](/uploads/r/null/0/9/4/0940512101117a85b6231a13707299e3e8d0a32f915633e8eb2a686cae8bf65f/549514d2-b532-4614-9728-1f16d7e0f62d-_A__Shape_of_training._Securing_the_future_of_excellent_patient_care._Final_report_of_the_independent_review._Led_by_Professor_David_Greenaway._October_2013_142.jpg)
![[Fi] NHS Seven Day Services Clinical Standards 2017.pdf](/uploads/r/null/6/5/9/659a6376b0a437758a65e04eb5d8abb614de10cec400e97428d2e4bdba4d015e/faa75457-84a8-4a2b-8ef3-c2956e033640-_Fi__NHS_Seven_Day_Services_Clinical_Standards_2017_142.jpg)
Pièce
Fait partie de UoA 2
![[Fiii] NHS Seven Day Services Clinical Standards 2017.pdf](/uploads/r/null/6/8/0/68035559b1b6fb0afb2a5a7f61ef99155d0e674a7ccaf49de9a24435689dd0cd/7c96592e-bc81-4374-bb74-86c2a304aea5-_Fiii__NHS_Seven_Day_Services_Clinical_Standards_2017_142.jpg)
Pièce
Fait partie de UoA 2
![[A] UK Government Coronavirus Action Plan, 3 March 2020.pdf](/uploads/r/null/d/0/b/d0b72e37ac87b2b6dc523b65bef294eef5ebc515a16070ef9ef1910328b309ab/76f42a6a-184d-4469-9189-3614ca736f35-_A__UK_Government_Coronavirus_Action_Plan__3_March_2020_142.jpg)
Pièce
Fait partie de UoA 2
![[Civ] Reports from Imperial College considered at SAGE meetings Meeting 13, 5th March 2020.pdf](/uploads/r/null/9/0/7/907c42af2864e3ae81282939e005702be9b6ee477bac0bdcbd3c0c4958a34a88/43f0fc8b-3a78-439d-a6ae-0d7e26b13dd3-_Civ__Reports_from_Imperial_College_considered_at_SAGE_meetings_Meeting_13__5th_March_2020_142.jpg)